Tau phosphorylated at threonine‐217 (p‐tau217) can be readily detected in CSF, and it is increased in AD (preprint: Barthélemy et al, 2017; Barthélemy et al, 2019; Sato et al, 2018). Here, MAPT is linked to Alzheimer disease.